Keratosis: Clinical Trials

131 trials for Keratosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

87 completed, 19 unknown, 8 recruiting, 6 not yet recruiting. 131 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable131Completed 87, Unknown 19, Recruiting 8, Not yet recruiting 6, Withdrawn 5, Terminated 4, Active not recruiting 2

Follow Keratosis: new trials by email Literature Review of Keratosis trials Research Report on Keratosis

Trials (filtered) newest first · largest first

All 131 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Induction of Dermal Remodeling in Veterans to Prevent Actinic Neoplasia Caused by Chronic Environmental Exposure to Ultraviolet Radiation
Microneedling, Trichloroacetic acid peel - Nonmelanoma Skin Cancer, Actinic Keratosis
Not applicableNot yet recruitingVA Office of Research and Development962026-11-012026-10-06
Acupuncture Combined With Transcutaneous Electrical Acupoint Stimulation for Constipation-Predominant Irritable Bowel Syndrome With Anxiety State
Acupuncture, Transcutaneous Electrical Acupoint Stimulation, Sham Transcutaneous Electrical Acupoint Stimulation - IBS, Constipation Predominant, Anxiety State
Not applicableNot yet recruitingThe First Affiliated Hospital of Zhejiang Chinese Medical University582026-10-012026-10-28
Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Ichthyosis
Doublebase Once - Ichthyosis
Not applicableNot yet recruitingDermal Laboratories Ltd1002026-09-072026-09-08
Multimodal Laser Treatment of Photodamaged Skin
1927-nm thulium laser, 1550-nm Er:Glass laser, Intense Pulsed Light - Photo-damage, Actinic Keratosis (AK)
Not applicableRecruitingMerete Haedersdal352026-09-012026-09-09
Transcutaneous Electrical Acustimulation for IBS-D: A Multicenter Study
Portable stimulator - IBS, Diarrhea Predominant
Not applicableNot yet recruitingFirst People's Hospital of Foshan2002026-03-012026-02-20
Instrumental Assessment of Plantar Hyperkeratosis in Healthy Subjects and Patients With Diabetes
Instrumental Assessment of Plantar Hyperkeratosis - Diabetes Mellitus, Hyperkeratosis
Not applicableNot yet recruitingUniversity of Seville502026-02-012026-02-17
Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn
Corn snack containing 25 grams available carbohydrate, Dextrose control - Glycemic Index, Glycemic Load
Not applicableCompletedPepsiCo Global R&D292026-01-082026-03-16
The Beneficial Effects on the Intestinal Function of a Food Supplement Based on an Extract of Green Tea and a Pool of Probiotics in Subjects With Irritable Bowel Syndrome With Predominance of Constipation
food supplement based on a mixture of green tea extract and a pool of probiotics., Placebo - IBS, Constipation Predominant
Not applicableRecruitingAdamas Biotech S.r.l.642025-07-302025-08-05
Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses
Tested product group, Control group - Actinic Keratosis (AK)
Not applicableRecruitingCosmetique Active International802025-07-012026-01-12
Optimizing the Timing for Facial Surgical Dressing Removal
sterile gauze dressing - Nevus, Seborrheic Keratosis (SK)
Not applicableCompletedUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1442025-06-152026-03-03
A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement
Apply a cream containing 0.05% marula oil-derived ceramide NPs - Atopic Dermatitis (AD), Psoriasis
Not applicableCompletedShanghai Chicmax Cosmetic Co., Ltd.322025-02-062025-07-15
Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK
We conducted an intra-patient, comparative study of idl-PDT with two illumination durations, 1 hour vs. 2 hours, using methyl aminolevulinate and a white LED light for the treatment of scalp AK. - Actinic Keratosis (AK)
Not applicableCompletedSan Salvatore Hospital of L'Aquila552025-01-022025-12-18
Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses
5-FU (fluorouracil), Calcipotriol - Actinic Keratosis of Face and Scalp, Actinic Keratoses
Not applicableNot yet recruitingSt Vincent's University Hospital, Ireland502025-01-012024-11-12
Effect of 1% Andaliman Fruit Extract Cream on Facial Seborrheic Keratosis
1% Andaliman Fruit Extract Cream - Seborrheic Keratosis
Not applicableCompletedUniversitas Sumatera Utara402025-01-012026-01-12
Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses Treatment
light curettage, Pre irradiation of 1 hour, Pre irradiation of 3 hour - Actinic Keratoses
Not applicableCompletedUniversity of Nove de Julho42024-11-302026-07-29
Characterization of the Cytokine Profile and the Microbiome in Darier's Disease
skin biopsies and blood extraction - Darier Disease
Not applicableRecruitingUniversity Hospital, Toulouse402024-11-042024-12-11
Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses
Half-dose illumination protocol, Full-dose illumination protocol - Actinic Keratoses
Not applicableUnknownFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal202024-08-012024-08-09
Guatemala Biofortified Maize Study
Biofortified maize, Placebo - Zinc Absorption, Iron Absorption
Not applicableCompletedUniversity of Colorado, Denver562024-07-312026-05-08
Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics
skin biopsies - Skin Cancer
Not applicableUnknownUniversity Hospital, Bordeaux2002024-07-042024-07-08
(FODMAP) Diet on Improving Symptoms of Patients With Irritable Bowel Syndrome
Low Fermentable, Oligo-, Di-, Monosaccharides and Polyols (FODMAP) Diet - Irritable Bowel Disease
Not applicableCompletedZagazig University1832024-06-012025-12-23

Showing 20 of 131. Sign in to see all of them.

Narrower conditions

Keratosis, Actinic (64)  ·  Callosities (14)  ·  Ichthyosis Bullosa of Siemens (11)  ·  Cholesteatoma (9)  ·  Irritable Bowel Syndrome (9)  ·  Keratosis, Seborrheic (9)  ·  Ichthyosis (7)  ·  Carcinoma, Basal Cell (4)  ·  Ichthyosis Vulgaris (4)  ·  Keratoderma, Palmoplantar, Epidermolytic (4)  ·  Carcinoma, Squamous Cell (3)  ·  Cholesteatoma, Middle Ear (3)  ·  Dermatitis, Atopic (3)  ·  Melanoma (3)

Broader conditions

Skin and Connective Tissue Diseases (131)  ·  Skin Diseases (130)  ·  Neoplasms (71)  ·  Precancerous Conditions (65)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (29)  ·  Congenital Abnormalities (24)  ·  Genetic Diseases, Inborn (24)  ·  Skin Abnormalities (24)  ·  Skin Diseases, Genetic (24)  ·  Infant, Newborn, Diseases (20)  ·  Ichthyosis (17)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Neoplasms by Histologic Type (10)  ·  Colonic Diseases (9)

Interventions

Photochemotherapy (6)  ·  Aminolevulinic Acid (5)  ·  Fluorouracil (4)  ·  methyl 5-aminolevulinate (3)  ·  3-ingenyl angelate (2)  ·  Biopsy (2)  ·  Blue Light (2)  ·  Curettage (2)  ·  Lasers, Dye (2)  ·  Phototherapy (2)  ·  Salicylic Acid (2)  ·  Tomography, Optical Coherence (2)  ·  Acetaminophen (1)  ·  Acupuncture Therapy (1)  ·  Amaranth Dye (1)

Sponsors

Northwestern University (7)  ·  University of California, Davis (6)  ·  University Hospital, Toulouse (4)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (3)  ·  University Hospital, Bordeaux (3)  ·  University of Colorado, Denver (3)  ·  University of Sao Paulo (3)  ·  Bispebjerg Hospital (2)  ·  Cosmetique Active International (2)  ·  Kerecis Ltd. (2)  ·  Merete Haedersdal (2)  ·  Novoxel Ltd. (2)  ·  Oy Karl Fazer Ab (2)  ·  Pulse Biosciences, Inc. (2)  ·  Shanghai Dermatology Hospital (2)

Countries

United States (39)  ·  France (15)  ·  Denmark (6)  ·  Brazil (5)  ·  China (5)  ·  Germany (5)  ·  Egypt (4)  ·  Italy (4)  ·  Bangladesh (3)  ·  Canada (3)  ·  Finland (3)  ·  Belgium (2)  ·  Guatemala (2)  ·  Indonesia (2)  ·  Israel (2)

Top investigators

Murad Alam, MD (4)  ·  Mir Misbahuddin, MBBS, PhD (3)  ·  Assi Levi, MD (2)  ·  Laurent Mortier, MD, PhD (2)  ·  Luis A Torezan, MD (2)  ·  Michael Hambidge, MD (2)  ·  Richard A Nuccitelli, PhD (2)  ·  Alain Hovnanian, MD, PhD (1)  ·  Amy Paller, MD (1)  ·  Amy S Paller, MD (1)  ·  Analice A Kamala, MSc (1)  ·  Ann Russell, PhD (1)  ·  Barry Galitzer, MD (1)

Results publications

PMID 17151593, PMID 17488399, PMID 17488400, PMID 19638214, PMID 22136038, PMID 23815349, PMID 24033340, PMID 24920311, PMID 25411289, PMID 25561207, PMID 25727104, PMID 25733467, PMID 25950503, PMID 26178727, PMID 26447158, PMID 26843523, PMID 27144627, PMID 27375183, PMID 27453064, PMID 27466608, PMID 27500794, PMID 28489298, PMID 28514458, PMID 29427796, PMID 29528727, PMID 29955700, PMID 30367470, PMID 30868672, PMID 30887613, PMID 31025952, PMID 31025953, PMID 31143849, PMID 31254130, PMID 31327218, PMID 31736123, PMID 31809349, PMID 32153925, PMID 32387665, PMID 32492125, PMID 33605440, PMID 34307321, PMID 34428179, PMID 34541702, PMID 34543653, PMID 34743007, PMID 34851451, PMID 35088760, PMID 35260030, PMID 35491738, PMID 35663767

NIH funding

2016 (1), R01AT007137 (1), R21AT003619 (1), UL1TR001436 (1)